In non-severe COVID-19 patients, Thevarajan et al. detected immunoglobulin M (IgM) and IgG antibodies that bound to SARS-CoV-2 in blood, and found that CD4+ T cells and CD8+ T cells were activated (Thevarajan et al., 2020). The gene discussed is CD8A; the disease is COVID-19.